Grund Nicholas bought AKBA
January 30, 2026 · Form 4 insider transaction
Grund Nicholas bought 204,000 shares of Akebia Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
204,000
Price
$0.00
Total value
N/A
InsiderGrund Nicholas
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 30, 2026
Filing dateFebruary 3, 2026
Shares owned after646,579
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.